Penserra Capital Management LLC Arvinas, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$65.85 - $96.21 $74,081 - $108,236	-1,125 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $732 - $1,078	10 Added 0.9%	1,125 $92,000
Q2 2021 Aug 12, 2021	BUY	$60.45 - $84.26 $2,418 - $3,370	40 Added 3.72%	1,115 $85,000
Q1 2021 May 13, 2021	BUY	$58.19 - $91.37 $8,146 - $12,791	140 Added 14.97%	1,075 $71,000
Q4 2020 Feb 12, 2021	BUY	$20.19 - $84.93 $12,093 - $50,873	599 Added 178.27%	935 $79,000
Q3 2020 Nov 13, 2020	BUY	$22.99 - $36.34 $7,724 - $12,210	336 New	336 $7,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.